Frankfurt - Delayed Quote EUR

ResMed Inc. (RME.F)

220.90
-0.80
(-0.36%)
At close: 3:56:43 PM GMT+2
Loading Chart for RME.F
  • Previous Close 221.70
  • Open 216.20
  • Bid 218.90 x 20000
  • Ask 220.50 x 20000
  • Day's Range 216.20 - 220.90
  • 52 Week Range 162.65 - 248.90
  • Volume 34
  • Avg. Volume 7
  • Market Cap (intraday) 33.089B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 27.75
  • EPS (TTM) 7.96
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield 1.88 (0.85%)
  • Ex-Dividend Date May 8, 2025
  • 1y Target Est --

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

www.resmed.co.in

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RME.F

View More

Performance Overview: RME.F

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RME.F
0.11%
S&P 500 (^GSPC)
1.00%

1-Year Return

RME.F
11.43%
S&P 500 (^GSPC)
11.91%

3-Year Return

RME.F
19.76%
S&P 500 (^GSPC)
52.27%

5-Year Return

RME.F
56.43%
S&P 500 (^GSPC)
99.91%

Compare To: RME.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RME.F

View More

Valuation Measures

Annual
As of 5/19/2025
  • Market Cap

    33.21B

  • Enterprise Value

    33.13B

  • Trailing P/E

    27.83

  • Forward P/E

    23.81

  • PEG Ratio (5yr expected)

    1.48

  • Price/Sales (ttm)

    7.28

  • Price/Book (mrq)

    6.56

  • Enterprise Value/Revenue

    7.38

  • Enterprise Value/EBITDA

    21.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.15%

  • Return on Assets (ttm)

    14.01%

  • Return on Equity (ttm)

    25.81%

  • Revenue (ttm)

    5.02B

  • Net Income Avi to Common (ttm)

    1.31B

  • Diluted EPS (ttm)

    7.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    944.84M

  • Total Debt/Equity (mrq)

    15.14%

  • Levered Free Cash Flow (ttm)

    1.2B

Research Analysis: RME.F

View More

Company Insights: RME.F

Research Reports: RME.F

View More

People Also Watch